RSS

Tag Archive | "Class Action"

Avandia lawsuit

Tuesday, February 22, 2011

0 Comments

Louisiana has filed a lawsuit against GlaxoSmithKline for fraud involving the diabetes drug Avandia, alleging that the drug maker hid information about potential side effects of Avandia. The Avandia suit was filed last week by Louisiana Attorney General Buddy Caldwell, claiming that GlaxoSmithKline collected more than $36 million in Medicaid reimbursements from the state as […]

Continue reading...

Government report links Avandia to heart attacks

Saturday, February 20, 2010

0 Comments

The diabetes drug Avandia produced by GlaxoSmithKline is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released on 20., February of 2010. The senate report by the Senate Finance Committee also criticized the […]

Continue reading...

Avandia Drug Recall

Tuesday, January 20, 2009

0 Comments

Avandia produced by GlaxoSmithKline, is an oral diabetes medication intended to help those with type-2 diabetes better control their blood glucose levels. Generically classified as a thiazoliodinedione, Avandia is not indicated for those with insulin-dependent (type-1) diabetes. FDA scientists estimated in July 2007 that Avandia was associated with approximately 83,000 heart attacks since the drug came […]

Continue reading...

Arthritis Drug Vioxx Recalled

Sunday, July 27, 2008

0 Comments

Arthritis drug Vioxx (Rofecoxib) was recalled by Merck & Co., Inc. The Vioxx recall was voluntarily started by Merck to discontinue the COX-2 inhibitor in September, 2004. Person’s affected by the Vioxx side effects are urged to seek medical and legal help. The Vioxx Recall was prompted after a three year trial known as Adenomatous […]

Continue reading...

Trasylol Class Action Lawsuit Recall

Sunday, July 27, 2008

0 Comments

FDA recently issued a public health advisory about the possibility of serious side effects from Trasylol (aprotinin), a drug used to prevent perioperative blood loss in patients undergoing CABG surgery. The advisory was based on two recently published observational studies. One reported that Trasylol may be associated with an increased risk of MI, stroke and […]

Continue reading...